In silico analysis of the binding of anthelmintics to Caenorhabditis elegans P-glycoprotein 1

Aller, 2009, Structure of p-glycoprotein reveals a molecular basis for poly-specific drug binding, Science, 323, 1718, 10.1126/science.1168750 Ardelli, 2013, Inhibition of P-glycoprotein enhances sensitivity of Caenorhabditis elegans to ivermectin, Vet. Parasitol., 191, 264, 10.1016/j.vetpar.2012.09.021 Bessadok, 2011, Recognition of sulfonylurea receptor (ABCC8/9) ligands by the multidrug resistance transporter P-glycoprotein (ABCB1): functional similarities based on common structural features between two multispecific ABC proteins, J. Biol. Chem., 286, 3552, 10.1074/jbc.M110.155200 Bygarski, 2014, Resistance to the macrocyclic lactone moxidectin is mediated in part by membrane transporter P-glycoproteins: implications for control of drug resistant parasitic nematodes, Int. J. Parasitol. Drugs Drug Resist, 4, 143, 10.1016/j.ijpddr.2014.06.002 Cully, 1994, Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans, Nature, 371, 707, 10.1038/371707a0 Domicevica, 2015, Homology modelling of human P-glycoprotein, Biochem. Soc. Trans., 43, 952, 10.1042/BST20150125 Dupuy, 2010, Interaction of anthelmintic drugs with P-glycoprotein in recombinant LLC-PK1-mdr1a cells, Chem. Biol. Interact., 186, 280, 10.1016/j.cbi.2010.05.013 Eckford, 2009, ABC efflux pump-based resistance to chemotherapy drugs, Chem. Rev., 109, 2989, 10.1021/cr9000226 Edgar, 2004, MUSCLE: multiple sequence alignment with high accuracy and high throughput, Nucleic Acids Res., 32, 1792, 10.1093/nar/gkh340 Efferth, 1993, Reversal of doxorubicin-resistance in sarcoma 180 tumor cells by inhibition of different resistance mechanisms, Cancer Lett., 70, 197, 10.1016/0304-3835(93)90231-W Elmshauser, 2014, Brain penetration of emodepside is increased in P-glycoprotein-deficient mice and leads to neurotoxicosis, J. Vet. Pharmacol. Ther., 38, 74, 10.1111/jvp.12149 Forrester, 2003, Haemonchus contortus: HcGluCla expressed in Xenopus oocytes forms a glutamate-gated ion channel that is activated by ibotenate and the antiparasitic drug ivermectin, Mol. Biochem. Parasitol., 129, 115, 10.1016/S0166-6851(03)00102-6 Godoy, 2015, Characterization of Haemonchus contortus P-glycoprotein-16 and its interaction with the macrocyclic lactone anthelmintics, Mol. Biochem. Parasitol., 204, 11, 10.1016/j.molbiopara.2015.12.001 Godoy, 2016, Characterisation of P-glycoprotein-9.1 in Haemonchus contortus, Parasit. Vectors, 9, 52, 10.1186/s13071-016-1317-8 Godoy, 2015, Haemonchus contortus P-glycoprotein-2: in situ localisation and characterisation of macrocyclic lactone transport, Int. J. Parasitol., 45, 85, 10.1016/j.ijpara.2014.09.008 Haubertin, 2006, Molecular dynamics simulations of E. coli MsbA transmembrane domain: formation of a semipore structure, Biophys. J., 91, 2517, 10.1529/biophysj.106.084020 Hayeshi, 2006, The potential inhibitory effect of antiparasitic drugs and natural products on P-glycoprotein mediated efflux, Eur. J. Pharm. Sci., 29, 70, 10.1016/j.ejps.2006.05.009 Higgins, 1992, ABC transporters: from microorganisms to man, Annu. Rev. Cell Biol., 8, 67, 10.1146/annurev.cb.08.110192.000435 Jabbar, 2006, Anthelmintic resistance: the state of play revisited, Life Sci., 79, 2413, 10.1016/j.lfs.2006.08.010 James, 2009, Increased expression of ABC transport proteins is associated with ivermectin resistance in the model nematode Caenorhabditis elegans, Int. J. Parasitol., 39, 213, 10.1016/j.ijpara.2008.06.009 Janssen, 2013, Caenorhabditis elegans: modest increase of susceptibility to ivermectin in individual P-glycoprotein loss-of-function strains, Exp. Parasitol., 134, 171, 10.1016/j.exppara.2013.03.005 Jin, 2012, Crystal structure of the multidrug transporter P-glycoprotein from Caenorhabditis elegans, Nature, 490, 566, 10.1038/nature11448 Jones, 2005, Multidrug resistance in parasites: ABC transporters, P-glycoproteins and molecular modelling, Int. J. Parasitol., 35, 555, 10.1016/j.ijpara.2005.01.012 Kaplan, 2004, Drug resistance in nematodes of veterinary importance: a status report, Trends Parasitol., 20, 477, 10.1016/j.pt.2004.08.001 Kaschny, 2015, Macrocyclic lactones differ in interaction with recombinant P-glycoprotein 9 of the parasitic nematode Cylicocylus elongatus and ketoconazole in a yeast growth assay, PLoS Pathog., 11, e1004781, 10.1371/journal.ppat.1004781 Kerboeuf, 2011, Anthelmintics are substrates and activators of nematode P glycoprotein, Antimicrob. Agents Chemother., 55, 2224, 10.1128/AAC.01477-10 Kiki-Mvouaka, 2010, Role of P-glycoprotein in the disposition of macrocyclic lactones: a comparison between ivermectin, eprinomectin, and moxidectin in mice, Drug Metab. Dispos., 38, 573, 10.1124/dmd.109.030700 Koenderink, 2010, The ABCs of multidrug resistance in malaria, Trends Parasitol., 26, 440, 10.1016/j.pt.2010.05.002 Lage, 2003, ABC-transporters: implications on drug resistance from microorganisms to human cancers, Int. J. Antimicrob. Agents, 22, 188, 10.1016/S0924-8579(03)00203-6 Laing, 2011, Annotation of two large contiguous regions from the Haemonchus contortus genome using RNA-seq and comparative analysis with Caenorhabditis elegans, PLoS One, 6, e23216, 10.1371/journal.pone.0023216 Laing, 2013, The genome and transcriptome of Haemonchus contortus, a key model parasite for drug and vaccine discovery, Genome Biol., 14, R88, 10.1186/gb-2013-14-8-r88 Leonard, 2003, The role of ABC transporters in clinical practice, Oncologist, 8, 411, 10.1634/theoncologist.8-5-411 Lespine, 2007, Interaction of macrocyclic lactones with P-glycoprotein: structure-affinity relationship, Eur. J. Pharm. Sci., 30, 84, 10.1016/j.ejps.2006.10.004 Lespine, 2012, P-glycoproteins and other multidrug resistance transporters in the pharmacology of anthelmintics: prospects for reversing transport-dependent anthelmintic resistance, Int. J. Parasitol. Drugs Drug Resist., 2, 58, 10.1016/j.ijpddr.2011.10.001 Li, 2014, Refined structures of mouse P-glycoprotein, Protein Sci., 23, 34, 10.1002/pro.2387 Loo, 2006, Transmembrane segment 1 of human P-glycoprotein contributes to the drug-binding pocket, Biochem. J., 396, 537, 10.1042/BJ20060012 Loo, 2006, Transmembrane segment 7 of human P-glycoprotein forms part of the drug-binding pocket, Biochem. J., 399, 351, 10.1042/BJ20060715 Loo, 2001, Defining the drug-binding site in the human multidrug resistance P-glycoprotein using a methanethiosulfonate analog of verapamil, MTS-verapamil, J. Biol. Chem., 276, 14972, 10.1074/jbc.M100407200 Loo, 2002, Location of the rhodamine-binding site in the human multidrug resistance P-glycoprotein, J. Biol. Chem., 277, 44332, 10.1074/jbc.M208433200 Mani, 2016, Interaction of macrocyclic lactones with a Dirofilaria immitis P-glycoprotein, Int. J. Parasitol., 46, 631, 10.1016/j.ijpara.2016.04.004 Menez, 2016, Acquired tolerance to ivermectin and moxidectin after drug selection pressure in the nematode Caenorhabditis elegans, Antimicrob. Agents Chemother., 60, 4809, 10.1128/AAC.00713-16 Moreno, 2010, Ivermectin disrupts the function of the excretory-secretory apparatus in microfilariae of Brugia malayi, Proc. Natl. Acad. Sci. U. S. A., 107, 20120, 10.1073/pnas.1011983107 Morris, 2009, AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility, J. Comput. Chem., 30, 2785, 10.1002/jcc.21256 Osei-Atweneboana, 2011, Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus, PLoS Negl. Trop. Dis., 5, e998, 10.1371/journal.pntd.0000998 Osei-Atweneboana, 2007, Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study, Lancet, 369, 2021, 10.1016/S0140-6736(07)60942-8 Prichard, 2012, Moxidectin and the avermectins: consanguinity but not identity, Int. J. Parasitol. Drugs Drug Resist., 2, 134, 10.1016/j.ijpddr.2012.04.001 Roulet, 2003, MDR1-deficient genotype in Collie dogs hypersensitive to the P-glycoprotein substrate ivermectin, Eur. J. Pharmacol., 460, 85, 10.1016/S0014-2999(02)02955-2 Schinkel, 1997, The physiological function of drug-transporting P-glycoproteins, Semin. Cancer Biol., 8, 161, 10.1006/scbi.1997.0068 Schinkel, 1994, Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs, Cell, 77, 491, 10.1016/0092-8674(94)90212-7 Seeger, 2009, Molecular basis of multidrug transport by ABC transporters, Biochim. Biophys. Acta, 1794, 725, 10.1016/j.bbapap.2008.12.004 Shilling, 2006, New light on multidrug binding by an ATP-binding-cassette transporter, Trends Pharmacol. Sci., 27, 195, 10.1016/j.tips.2006.02.008 Sousa, 2006, Protein-ligand docking: current status and future challenges, Proteins, 65, 15, 10.1002/prot.21082 Sousa, 2013, Protein-ligand docking in the new millennium–a retrospective of 10 years in the field, Curr. Med. Chem., 20, 2296, 10.2174/0929867311320180002 Szewczyk, 2015, Snapshots of ligand entry, malleable binding and induced helical movement in P-glycoprotein, Acta crystallogr. Sect. D Biol. Crystallogr., 71, 732, 10.1107/S1399004715000978 Ward, 2007, Flexibility in the ABC transporter MsbA: alternating access with a twist, Proc. Natl. Acad. Sci. U. S. A., 104, 19005, 10.1073/pnas.0709388104 Yan, 2012, The role of several ABC transporter genes in ivermectin resistance in Caenorhabditis elegans, Vet. Parasitol., 190, 519, 10.1016/j.vetpar.2012.06.038 Zhao, 2004, Expression analysis of ABC transporters reveals differential functions of tandemly duplicated genes in Caenorhabditis elegans, J. Mol. Biol., 344, 409, 10.1016/j.jmb.2004.09.052